Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis

Jeffrey S. Wagener, Lawrence Rasouliyan, Donald R. Vandevanter, David J. Pasta, Warren E. Regelmann, Wayne J. Morgan, Michael W. Konstan

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences